Max S. Topp

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia”.

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood(2020)10.1182/blood.2020007732

N/A

4.0DataRank · unranked

322 citations

Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more

Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell–redirecting therapy

Blood(2023)10.1182/blood.2023021672

N/A

0.612DataRank · unranked

58 citations

Alexander M. Leipold, Silke Appenzeller, Viktoria Fuhr, Hilka Rauert‐Wunderlich, Matteo Da Vià +13 more

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

Cancer(2020)10.1002/cncr.33298

N/A

0DataRank · unranked

32 citations

Nicola Gökbuget, Gerhard Zugmaier, Anthony S. Stein, Hervé Dombret, Yuqi Chen +5 more

CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS

Hematological Oncology(2021)10.1002/hon.6_2880

N/A

0DataRank · unranked

1 citations

Nathalie Fiaschi, Raquel P. Deering, Ankur Dhanik, Kamil J. Cygan, W Zhang +19 more